<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595309/" ref="ordinalpos=2806&amp;ncbi_uid=5868713&amp;link_uid=PMC3595309" image-link="/pmc/articles/PMC3595309/figure/F2/" class="imagepopup">Figure. From: Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NF?B <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"><b>Figure 2.</b> Inhibition of CDH17 repressed the malignant potency of MKN-45 cells and alleviated the activation of NFκB signaling pathway. <b>(A)</b> Immunofluorescence staining demonstrated that CDH17 was significantly downregulated in miR-CDH17 cells, compared with the high expression in both MKN-45 and miR-neg cells (100μm). <b>(B)</b> Proliferation assay.<b> (C) </b>Adhesion assay. <b>(D)</b> Cell cycle analysis. <b>(E)</b> Invasion assay (100μm). <b>(F)</b> In western blot analysis, there was less expression of CDH17, nuclear p65, MMP-9 and VEGF-C, but more expression of IκB-α in miR-CDH17 group. There was no difference in total p65 among each group.</div></div>